Electroconvulsive is an effective treatment option that should remain available for use, with proper ethical safeguards, for the treatment of severe clinical depression.
Physicians need to take an active role in improving the genetic literacy of the general population and also push for public health policies that make new genetic tools available to everyone.
Medical ethicists have discussed the use of race classification in determining disease prevalence and the response of specific ethnic groups to different medications.